Johannes W G Jacobs
Jan 1, 2021
Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis
Rubbert-Roth A, Aletaha D, Devenport J, Sidiropoulos P, Luder Y, Edwardes M, Jacobs J. Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis. Rheumatology (Oxford) 2021; 60:682-691.
Jan 1, 2021Effect of disease duration and other characteristics on efficacy outcomes in clinical trials of tocilizumab for rheumatoid arthritis
Jan 1, 2021Rheumatology (Oxford) 2021; 60:682-691
Rubbert-Roth Andrea, Aletaha Daniel, Devenport Jenny, Sidiropoulos Paris N, Luder Yves, Edwardes Michael D, Jacobs Johannes W G
more
Jun 23, 2017
A disconnect between disease activity and functional ability already in patients with early rheumatoid arthritis, depending on large joint involvement
Rubbert-Roth A, Jacobs J, Bijlsma J, Welsing P. A disconnect between disease activity and functional ability already in patients with early rheumatoid arthritis, depending on large joint involvement. Ann Rheum Dis 2017; 77:1085-1086.
Jun 23, 2017A disconnect between disease activity and functional ability already in patients with early rheumatoid arthritis, depending on large joint involvement
Jun 23, 2017Ann Rheum Dis 2017; 77:1085-1086
Rubbert-Roth Andrea, Jacobs Johannes W G, Bijlsma Johannes W J, Welsing Paco M J
more